| 產(chǎn)品名稱(chēng) | HCM-BROD-0027-C34 |
|---|---|
| 商品貨號(hào) | B161703 |
| Organism | Homo sapiens, human |
| Tissue | Lung, derived from metastatic site: brain |
| Product Format | frozen 1.0 mL |
| Morphology | neuronal |
| Culture Properties | suspension/aggregate |
| Biosafety Level | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease | malignant neoplasm of bronchus and lung |
| Age | See associated clinical data for patient profile information, if available. https://portal.gdc.cancer.gov/ https://hcmi-searchable-catalog.nci.nih.gov/model/HCM-BROD-0027-C34 |
| Gender | See associated clinical data for patient profile information, if available. https://portal.gdc.cancer.gov/ https://hcmi-searchable-catalog.nci.nih.gov/model/HCM-BROD-0027-C34 |
| Ethnicity | See associated clinical data for patient profile information, if available. https://portal.gdc.cancer.gov/ https://hcmi-searchable-catalog.nci.nih.gov/model/HCM-BROD-0027-C34 |
| Applications | Basic research, compound screening. |
| Storage Conditions | liquid nitrogen vapor phase |
| Images |  |
| Clinical Data | ICD-10-CM code: C34, malignant neoplasm of bronchus and lung See associated clinical data for patient profile information, if available.https://portal.gdc.cancer.gov/ https://hcmi-searchable-catalog.nci.nih.gov/model/HCM-BROD-0027-C34 |
| Comments | Next-generation cancer model from the Human Cancer Models Initiate (HCMI). Refer to the following websites for additional information on this model including protocols, clinical information, and bioinformatics data. https://ocg.cancer.gov/programs/hcmi/resources https://portal.gdc.cancer.gov/ https://hcmi-searchable-catalog.nci.nih.gov/model/HCM-BROD-0027-C34 |
| Complete Growth Medium | NeuroCult NS-A Basal Medium (StemCell Technologies #05750) with NS-A Proliferation Supplement (StemCell Technologies #05754) + 20 ng/mL EGF (StemCell Technologies #78003.1) + 20 ng/mL bFGF (Peprotech #AF-100-15) + 2 µg/mL Heparin (StemCell Technologies #07980). Prepare media according to the manufacturer’s instructions: Stem Cell Technologies Catalog #5751 |
| Subculturing | Important: use Ultra Low Attachment (ULA) flasks/plates when culturing this model such as Corning #3814. Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2.5-5 X 105 cells/mL and maintain between below 1 X 106 cells/mL.
Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density). Large neurospheres should be mechanically dissociated to small fragments by repeated pipetting. Do not dissociate to single cells. |
| Cryopreservation | Complete growth media containing 10% DMSO (ATCC 4-X) |
| Culture Conditions | Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37°C |
| Cells per Vial | ≥ 1 x 106 cells |
| Volume | 1.0 mL |
| STR Profile | Amelogenin: X
CSF1PO: 12,13
D13S317: 11
D16S539: 9,11
D5S818: 11,13
D7S820: 9,12
THO1: 7,8
TPOX: 8,10
vWA: 14,18 |
| Sterility Tests | Bacteria, yeast and fungi: No growth Mycoplasma: No growth |
| Viral Testing | Hepatitis B: None detected Cytomegalovirus: None detected Human immunodeficiency virus: None detected Epstein-Barr virus: None detected Human papillomavirus: None detected |
| Name of Depositor | Broad Institute |
| Year of Deposit | 2018 |
| 序號(hào) | 文章標(biāo)題 | 操作 |
|---|---|---|
| 1 | ATCC細(xì)胞運(yùn)輸和處理 | 查看詳情 |
| 2 | 其他海外品牌代理 | 查看詳情 |
| 3 | ATCC代理 | 查看詳情 |
| 4 | 購(gòu)買(mǎi)須知 | 查看詳情 |
| 5 | 訂購(gòu)流程 | 查看詳情 |
| 梅經(jīng)理 | 17280875617 | 1438578920 |
| 胡經(jīng)理 | 13345964880 | 2438244627 |
| 周經(jīng)理 | 17757487661 | 1296385441 |
| 于經(jīng)理 | 18067160830 | 2088210172 |
| 沈經(jīng)理 | 19548299266 | 2662369050 |
| 李經(jīng)理 | 13626845108 | 972239479 |
